- Phare
- Validé par KD/KO
Anticorps Monoclonal anti-WWTR1/TAZ
WWTR1/TAZ Monoclonal Antibody for WB, IHC, IF-P, Indirect ELISA
Hôte / Isotype
Mouse / IgG1
Réactivité testée
Humain, rat, souris
Applications
WB, IHC, IF-P, Indirect ELISA
Conjugaison
Non conjugué
CloneNo.
2A12A10
N° de cat : 66500-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
66500-1-PBS cible WWTR1/TAZ dans les applications de WB, IHC, IF-P, Indirect ELISA et montre une réactivité avec des échantillons Humain, rat, souris
| Réactivité | Humain, rat, souris |
| Hôte / Isotype | Mouse / IgG1 |
| Clonalité | Monoclonal |
| Type | Anticorps |
| Immunogène | WWTR1/TAZ Protéine recombinante Ag13330 |
| Nom complet | WW domain containing transcription regulator 1 |
| Masse moléculaire calculée | 44 kDa |
| Poids moléculaire observé | 55 kDa |
| Numéro d’acquisition GenBank | BC014052 |
| Symbole du gène | WWTR1 |
| Identification du gène (NCBI) | 25937 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
TAZ, also referred as WWTR1, is a transcriptional co-activator with a PDZ-binding motif that is regulated by its interaction with 14-3-3 protein. TAZ is expressed in many primary tumors, such as breast cancer, thyroid carcinoma, colorectal cancer, and glioma. TAZ has been reported to be one of the nuclear effectors of Hippo-related pathways that regulate organ size control, cancer stem cell (CSC) properties, and epithelial-mesenchymal transition (EMT). TAZ has been defined for its role in the nucleus, where it functions directly as a transcriptional regulator by interacting with several nuclear factors as Runx2/Cbfa1, NHERF-2, TEF-1, TBX5, PAX3, PAX8 and TTF-1.



















